Richard Sykes

Richard Sykes

Director/Board Member chez PDS BIOTECHNOLOGY CORPORATION

Fortune : 2 M $ au 31/03/2024

79 ans
Health Technology
Commercial Services
Consumer Services

Profil

Richard Brook Sykes is currently the Chairman of Metabometrix Ltd., Catalyst, UK Stem Cell Foundation, The Royal Institution of Great Britain, Omnicyte Ltd., The Singapore Biomedical Sciences Intl Advisory Council, Careers Research & Advisory Centre, DnaNudge Ltd., Higher Education Funding Council For England, PDS Biotechnology Corp., The Royal Society of Chemistry, Masdar Institute of Science & Technology, and President of Research & Development Society.
He previously served as the Chairman & Chief Executive Officer of Glaxo Wellcome Plc, GSK Plc, and GlaxoSmithKline Services Unlimited.
He was also the Non-Executive Chairman of Circassia Ltd., Vice Chairman of Lonza Group AG, Non-Executive Deputy Chairman of Eurasian Natural Resources Corp Ltd., Chairman of MerLion Pharmaceuticals Pte Ltd., and Chairman of Imperial College Healthcare NHS Trust.
Additionally, he held positions such as Non-Executive Chairman of NetScientific Plc, Chairman of RepRegen Ltd., Executive Chairman of Frontier Smart Technologies Group Ltd., Chairman of NHS London, Senior Independent Director of Rio Tinto Plc, Director-Emeritus of International AIDS Vaccine Initiative, Inc., Director of PDS Operating Corp., ContraFect Corp., and The Gregor Mendel Trust Ltd., and Director of EDBI Pte Ltd.
He also served as the Chancellor of Brunel University and President of The Institute For Employment Studies.
Dr. Sykes received his undergraduate and doctorate degrees from the University of London and a doctorate degree from the University of Bristol.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/07/2023 445 108 ( 1,43% ) 2 M $ 31/03/2024

Postes actifs de Richard Sykes

SociétésPosteDébut
PDS BIOTECHNOLOGY CORPORATION Director/Board Member 01/03/2019
Director/Board Member -
Research & Development Society President 01/01/2002
Careers Research & Advisory Centre Chairman 01/01/2008
Omnicyte Ltd. Chairman 01/01/2006
Masdar Institute of Science & Technology Director/Board Member -
Chairman -
Chairman 01/09/2010
UK Stem Cell Foundation Chairman 01/01/2004
░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Richard Sykes

Anciens postes connus de Richard Sykes

SociétésPosteFin
░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Richard Sykes

Formation de Richard Sykes

University of London Doctorate Degree
University of Bristol Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Richard Sykes

Relations

100 +

Relations au 1er degré

36

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
RIO TINTO PLC

Non-Energy Minerals

GSK PLC

Health Technology

LONZA GROUP AG

Health Technology

NETSCIENTIFIC PLC

Health Technology

CONTRAFECT CORPORATION

Health Technology

PDS BIOTECHNOLOGY CORPORATION

Health Technology

Entreprise privées26
Glaxo Wellcome Plc

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Non-Energy Minerals

Commercial Services

UK Stem Cell Foundation

Miscellaneous

Health Services

Commercial Services

Health Services

Electronic Technology

Masdar Institute of Science & Technology

Health Technology

Health Services

Commercial Services

Commercial Services

Omnicyte Ltd.

The Singapore Biomedical Sciences Intl Advisory Council

The Gregor Mendel Trust Ltd.

Careers Research & Advisory Centre

Finance

Health Services

Research & Development Society

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Richard Sykes